Thu, Aug 1, 9:15 PM (88 days ago)
Biotricity Inc. received a notification from the Nasdaq Capital Market on July 26, 2024, indicating that the company's closing bid price had been below $1.00 per share for 30 consecutive business days, failing to meet the Nasdaq Listing Rule 5550(a)(2). This notification does not immediately impact the listing or trading of Biotricity's common stock on the Nasdaq Capital Market. The company has until January 22, 2025, to regain compliance by achieving a closing bid price of at least $1.00 per share for ten consecutive business days. If Biotricity fails to meet this requirement, it may qualify for an additional 180-day compliance period, provided it meets other listing standards and notifies Nasdaq of its intention to rectify the deficiency, potentially through a reverse stock split. If compliance is not achieved, Biotricity risks delisting. The company is actively monitoring its stock price and considering options to regain compliance.